1. Home
  2. Labeler Index
  3. Eli Lilly Italia Spa
  4. 54568-471
  5. NDC Package Code: 54568-471-71 Tirzepatide

NDC Package 54568-471-71 Tirzepatide

Injection, Solution - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
54568-471-71
Package Description:
36 SYRINGE in 1 TRAY / .5 mL in 1 SYRINGE
Product Code:
54568-471
Non-Proprietary Name:
Tirzepatide
Substance Name:
Tirzepatide
11-Digit NDC Billing Format:
54568047171
Product Type:
Drug For Further Processing
Labeler Name:
Eli Lilly Italia Spa
Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Active Ingredient(s):
  • TIRZEPATIDE 10 mg/.5mL
    • Sample Package:
    N/A
    Marketing Category:
    DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
    Start Marketing Date:
    08-12-2022
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    54568-471-1624 CARTON in 1 BOX / 4 TRAY in 1 CARTON / 160 SYRINGE in 1 TRAY / .5 mL in 1 SYRINGE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 54568-471-71?

    The NDC Packaged Code 54568-471-71 is assigned to an UNFINISHED drug package of 36 syringe in 1 tray / .5 ml in 1 syringe of Tirzepatide, drug for further processing labeled by Eli Lilly Italia Spa. The product's dosage form is injection, solution and is administered via form.

    Is NDC 54568-471 included in the NDC Directory?

    Yes, Tirzepatide is an UNFINISHED PRODUCT with code 54568-471 that is active and included in the NDC Directory. The product was first marketed by Eli Lilly Italia Spa on August 12, 2022 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 54568-471-71?

    The 11-digit format is 54568047171. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-254568-471-715-4-254568-0471-71